US · Healthcare · Biotechnology
with an average price target of $43.50.
| Fund | Stake |
|---|---|
| Peregrine Capital Management,LLC | 0.26% |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Kardigan, Inc. Common Stock — free to start.
Google PlayApp StoreData updated 2026-08-05.